EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, greets Iowa voters at the Veterans Freedom Center in Dubuque, Iowa, on June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, greets Iowa voters at the Veterans Freedom Center in Dubuque, Iowa, on June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, greets Iowa voters at the Veterans Freedom Center in Dubuque, Iowa, on June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, in his campaign bus after a meet-and-greet in Bettendorf, Iowa, June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, in his campaign bus after a meet-and-greet in Bettendorf, Iowa, June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, in his campaign bus after a meet-and-greet in Bettendorf, Iowa, June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, in his campaign bus after a meet-and-greet in Bettendorf, Iowa, June 15, 2023. (Jordan Gale/The New York Times)
EditorialVivek Ramaswamy, the biotech millionaire turned Republican presidential candidate, in his campaign bus after a meet-and-greet in Bettendorf, Iowa, June 15, 2023. (Jordan Gale/The New York Times)
EditorialPresident Joe Biden speaks to reporters before boarding Air Force One at Joint Base Andrews in Maryland, Sept. 12, 2022. (Sarah Silbiger/The New York Times)
EditorialA Cassava Sciences nameplate on the exterior of an office building in Austin, Texas, April 18, 2022. (Ilana Panich-Linsman/The New York Times)
EditorialA $100 million complex for artificial intelligence and biotech companies being built by the University of Toronto, in downtown Toronto, March 9, 2022. (Brendan Ko/The New York Times)
EditorialMio funding by the federal government: The Hamburg-based biotech company Evotec is developing a drug against Covid-19, Hamburg, Germany - 04 Jan 2022